These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Studies on the synthesis and biological activity of 3-(substituted anilinomethyl)-4-(5-substituted-2-furfurylidene)amino-1,2,4 -triazole-5- thiones and their Mannich bases. Kalluraya B; Shetty SN; Gunaga P; Holla BS Boll Chim Farm; 1996 Dec; 135(11):638-42. PubMed ID: 9066173 [TBL] [Abstract][Full Text] [Related]
47. [Substances with central nervous system activity. Derivatives of 2,3,5,9b-tetrahydro-1,3-dioxo-1H-imidazo[5,1-a]isoindole-5 -carboxylic acid]. Occelli E; Fontanella L Farmaco Sci; 1984 Apr; 39(4):322-35. PubMed ID: 6723948 [TBL] [Abstract][Full Text] [Related]
48. New antihypertensive agents. I. Synthesis and antihypertensive activity of some 4-piperidylbenzimidazolinone derivatives. Obase H; Nakamizo N; Takai H; Teranishi M; Kubo K; Shuto K; Kasuya Y; Kato H; Shigenobu K; Kurihara J Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):462-73. PubMed ID: 7094146 [No Abstract] [Full Text] [Related]
49. Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA. Tunçbilek M; Kiper T; Altanlar N Eur J Med Chem; 2009 Mar; 44(3):1024-33. PubMed ID: 18718694 [TBL] [Abstract][Full Text] [Related]
50. N/C-4 substituted azetidin-2-ones: synthesis and preliminary evaluation as new class of antimicrobial agents. Halve AK; Bhadauria D; Dubey R Bioorg Med Chem Lett; 2007 Jan; 17(2):341-5. PubMed ID: 17098426 [TBL] [Abstract][Full Text] [Related]
51. Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. Yildiz-Oren I; Yalcin I; Aki-Sener E; Ucarturk N Eur J Med Chem; 2004 Mar; 39(3):291-8. PubMed ID: 15051178 [TBL] [Abstract][Full Text] [Related]
52. [Progresses in the field of pharmacology. 3]. Hörig C; Koch H; Mayr E; Selchau M Pharmazie; 1971 Sep; 26(9):509-33. PubMed ID: 4944695 [No Abstract] [Full Text] [Related]
53. Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase. Wittman MD; Balasubramanian B; Stoffan K; Velaparthi U; Liu P; Krishnanathan S; Carboni J; Li A; Greer A; Attar R; Gottardis M; Chang C; Jacobson B; Sun Y; Hansel S; Zoeckler M; Vyas DM Bioorg Med Chem Lett; 2007 Feb; 17(4):974-7. PubMed ID: 17187980 [TBL] [Abstract][Full Text] [Related]
54. New antihypertensive agents. II. Studies on new analogs of 4-piperidylbenzimidazolinones. Obase H; Nakamizo N; Takai H; Teranishi M; Kubo K; Shuto K; Kasuya Y; Shigenobu K Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):474-83. PubMed ID: 7094147 [No Abstract] [Full Text] [Related]
55. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines. Stýskala J; Stýskalová L; Slouka J; Hajdúch M Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255 [TBL] [Abstract][Full Text] [Related]
56. 2-Mercapto-N-(azolyl)benzenesulphonamides. IV. Syntheses of some 4-chloro-2-mercapto-5-methyl-N-(benzimidazol-2-yl)benzenesulph onamide derivatives with potential anticancer and anti-HIV activities. Pomarnacka E; Brzozowski Z Acta Pol Pharm; 1997; 54(3):215-21. PubMed ID: 9511447 [TBL] [Abstract][Full Text] [Related]
57. SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents. Jadhav GR; Shaikh MU; Kale RP; Shiradkar MR; Gill CH Eur J Med Chem; 2009 Jul; 44(7):2930-5. PubMed ID: 19150154 [TBL] [Abstract][Full Text] [Related]
58. Antifungal activity of organic and organometallic derivatives of benzimidazole and benzothiazole. Küçükbay H; Durmaz B Arzneimittelforschung; 1997 May; 47(5):667-70. PubMed ID: 9205784 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of derivatives of N-[4-substituted-1-piperazinylalkyl]-1-(butyl,aryl)-2,5- dimethylpyrrole-3,4-dicarboxymide (Part II). Malinka W; Sieklucka-Dziuba M; Robak J; Kleinrok Z Farmaco; 1994; 49(7-8):481-7. PubMed ID: 7945713 [TBL] [Abstract][Full Text] [Related]
60. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]